However, patients positive for NPM1 mutation had a significantly shorter median survival, though some researchers reported that NPM1 mutation conferred a favorable prognosis in AML patients with younger age or normal karyotype [57, 58]. Here, NPM1 is linked to acute myeloid leukemia.